Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia
Open Access
- 19 April 2022
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 12 (5) , 606
Abstract
Our aim was to evaluate the expression of biomarkers, CD44v6, CD147, EGFR, p53, p63, p73, p16, and podoplanin in oral leukoplakias (OL) and to assess their potential for prediction of malignant transformation (MT). We analyzed the expression of CD44v6, CD147, EGFR, p53, p63, p73, p16, and podoplanin by immunohistochemistry in 52 OL, comprised of 41 low-grade (LG) dysplasia and 11 high-grade (HG) cases. Twelve healthy normal tissues (NT) were also included. Univariate and multivariate analysis were performed to evaluate any association with MT. Variable expression among the studied markers was observed, with a significant increase of high expression from NT to LG and HG cases in CD44v6 (p = 0.002), P53 (p = 0.002), P73 (p = 0.043), and podoplanin (p < 0.001). In multivariate analysis, cases with high podoplanin score showed a significant increased risk of MT (HR of 10.148 (95% CI of 1.503–68.532; p = 0.017). Furthermore, podoplanin combined with binary dysplasia grade obtained a HR of 10.238 (95% CI of 2.06–50.889; p = 0.004). To conclude, CD44v6, p53, p73, and podoplanin showed an increasing expression along the natural history of oral carcinogenesis. Podoplanin expression independently or combined with dysplasia grade could be useful predictive markers of MT in OL.Keywords
Funding Information
- Cooperativa de Ensino Superior Politécnico e Universitário (IPO2021_PI2RL_IINFACTS_2021)
This publication has 74 references indexed in Scilit:
- Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humansOncology Letters, 2012
- Genetics/epigenetics of oral premalignancy: current status and future research*Oral Diseases, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral CancerCancer Prevention Research, 2010
- ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with LeukoplakiaClinical Cancer Research, 2009
- Treatment and follow‐up of oral dysplasia — A systematic review and meta‐analysisHead & Neck, 2009
- Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431Biochemical and Biophysical Research Communications, 2008
- Nomenclature and classification of potentially malignant disorders of the oral mucosaJournal of Oral Pathology & Medicine, 2007
- Molecular genetics of premalignant oral lesionsOral Diseases, 2007
- Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformationOral Oncology, 2006